Dakota Wealth Management lowered its position in shares of Clorox Co (NYSE:CLX) by 25.7% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 8,048 shares of the company’s stock after selling 2,778 shares during the period. Dakota Wealth Management’s holdings in Clorox were worth $1,291,000 at the end of the most recent quarter.
Several other institutional investors have also recently made changes to their positions in the company. Visionary Asset Management Inc. purchased a new stake in shares of Clorox in the fourth quarter valued at $225,000. Deutsche Bank AG grew its position in shares of Clorox by 10.2% in the fourth quarter. Deutsche Bank AG now owns 307,703 shares of the company’s stock valued at $47,425,000 after purchasing an additional 28,361 shares during the period. Phocas Financial Corp. purchased a new stake in shares of Clorox in the fourth quarter valued at $193,000. Oregon Public Employees Retirement Fund grew its position in shares of Clorox by 48,033.6% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 6,808,980 shares of the company’s stock valued at $44,000 after purchasing an additional 6,794,834 shares during the period. Finally, Montecito Bank & Trust grew its position in Clorox by 24.0% during the first quarter. Montecito Bank & Trust now owns 5,212 shares of the company’s stock valued at $836,000 after acquiring an additional 1,009 shares during the period. Hedge funds and other institutional investors own 77.91% of the company’s stock.
CLX has been the subject of a number of research reports. Zacks Investment Research raised Clorox from a “hold” rating to a “buy” rating and set a $177.00 price target for the company in a research report on Monday, March 11th. BMO Capital Markets set a $175.00 price target on Clorox and gave the company a “buy” rating in a research report on Tuesday, February 5th. Wells Fargo & Co reissued a “hold” rating and set a $157.00 price target on shares of Clorox in a research report on Thursday, February 21st. Barclays reissued a “hold” rating and set a $142.00 price target on shares of Clorox in a research report on Wednesday, February 6th. Finally, Citigroup set a $171.00 price objective on Clorox and gave the stock a “hold” rating in a research note on Tuesday, February 5th. Four analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $149.57.
In related news, SVP Andrew J. Mowery sold 5,340 shares of the business’s stock in a transaction dated Friday, March 1st. The stock was sold at an average price of $156.44, for a total value of $835,389.60. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.40% of the stock is owned by insiders.
Shares of NYSE:CLX traded up $2.42 during trading on Wednesday, hitting $150.60. The company’s stock had a trading volume of 1,050,059 shares, compared to its average volume of 1,046,028. The company has a debt-to-equity ratio of 2.93, a quick ratio of 0.66 and a current ratio of 1.10. Clorox Co has a fifty-two week low of $118.92 and a fifty-two week high of $167.70. The stock has a market cap of $18.73 billion, a price-to-earnings ratio of 24.06, a price-to-earnings-growth ratio of 4.28 and a beta of 0.31.
Clorox (NYSE:CLX) last released its quarterly earnings results on Wednesday, May 1st. The company reported $1.44 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $1.47 by ($0.03). The business had revenue of $1.55 billion during the quarter, compared to analyst estimates of $1.57 billion. Clorox had a return on equity of 108.82% and a net margin of 12.68%. The company’s revenue was up 2.2% compared to the same quarter last year. During the same quarter last year, the firm posted $1.37 EPS. On average, equities research analysts predict that Clorox Co will post 6.29 EPS for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 16th. Investors of record on Wednesday, July 31st will be issued a $1.06 dividend. This is a positive change from Clorox’s previous quarterly dividend of $0.96. This represents a $4.24 annualized dividend and a yield of 2.82%. The ex-dividend date of this dividend is Tuesday, July 30th. Clorox’s payout ratio is currently 61.34%.
ILLEGAL ACTIVITY WARNING: “Dakota Wealth Management Reduces Stake in Clorox Co (CLX)” was originally published by Sundance Herald and is the sole property of of Sundance Herald. If you are reading this article on another site, it was illegally copied and republished in violation of United States & international trademark and copyright legislation. The legal version of this article can be read at https://sundanceherald.com/2019/05/22/clorox-co-clx-shares-sold-by-dakota-wealth-management.html.
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
Featured Article: Index Funds
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.